Evidence map›Paper›PMID 40710562›Full record

ArticleMetabolites2025

Understanding the Metabolic Effects of Surgically Induced Renal Ischemia in Humans: A Temporal Approach.

Bhargav Arimilli, Tyler A On, Vaishnavi S Srirama, Ye Yang, Gitanjali Asampille, Jeffrey R Brender, Murali C Krishna, Jessica Y Hseuh, Viraj P Chegu, Zachary Kozel and 4 more

Abstract read
In one paragraph

Article in Metabolites, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bhargav ArimilliUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.ORCID 0000-0003-2815-6886
Tyler A OnUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Vaishnavi S SriramaUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.ORCID 0009-0002-6306-3730
Ye YangUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Gitanjali AsampilleUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Jeffrey R BrenderClinical Cancer Metabolism Facility, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Murali C KrishnaClinical Cancer Metabolism Facility, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Jessica Y HseuhUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Viraj P CheguUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Zachary KozelUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Sandeep GurramUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.ORCID 0000-0002-6405-9269
Mark W BallUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.ORCID 0000-0003-1780-2627
William Marston LinehanUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Daniel R CrooksUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

Funding

Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase GeneZIABC011038 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$29.8M
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD GeneZIABC011043 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2009 to 2025
$20.9M
Metabolomics CoreZICBC011932 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CROOKS, DANIEL · 2020 to 2025
$11.6M
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD GeneZ01BC011043 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LINEHAN, WILLIAM MARSTON · 2008 to 2008
$1.4M
Intramural NIH HHS Z01 BC011043Intramural NIH HHS ZIA BC011038Intramural NIH HHS ZIA BC011043Intramural NIH HHS ZIC BC011932
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ischemiametabolomicsNMR spectroscopy

Identifiers

PMID40710562
PMCPMC12300224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.